The Beers criteria role in predicting bleeding during the use of direct oral anticoagulants in patients with atrial fibrillation over 80 years of age
https://doi.org/10.20996/1819-6446-2025-3157
About the Authors
M. S. CherniaevaRussian Federation
Marina S. Cherniaeva
Moscow
M. A. Rozhkova
Russian Federation
Maria A. Rozhkova
Moscow
E. S. Ilyina
Russian Federation
Ekaterina S. Ilina
Moscow
E. A. Moiseeva
Russian Federation
Ekaterina A. Moiseeva
Moscow
E. A. Gorelov
Russian Federation
Egor A. Gorelov
Moscow
L. A. Egorova
Russian Federation
Larisa A. Egorova
Moscow
O. M. Maslennikova
Russian Federation
Olga M. Maslennikova
Moscow
N. V. Lomakin
Russian Federation
Nikita V. Lomakin
Moscow
D. A. Sychev
Russian Federation
Dmitry A. Sychev
Moscow
References
1. Van Gelder IC, Rienstra M, Bunting KV, et al; ESC Scientific Document Group. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio- Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314-414. DOI: 10.1093/eurheartj/ehae176.
2. Arakelyan MG, Bockeria LA, Vasilieva EY, et al. 2020 Clinical guidelines for Atrial fibrillation and atrial flutter. Russian Journal of Cardiology. 2021;26(7):4594. (In Russ.) DOI: 10.15829/1560-4071-2021-4594.
3. Praskurnichy EA, Morozova OI. Clinical status and burden of atrial fibrillation in obese individuals: assessment of the effects of implementing weight control programs. The Bulletin of Contemporary Clinical Medicine. 2021;14(4):15-26. (In Russ.) DOI: 10.20969/VSKM.2021.14(4).15-26.
4. Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154-62. DOI: 10.1016/S0140-6736(14)61774-8.
5. Tkacheva ON, Vorobyova NM, Kotovskaya YuV, et al. Antithrombotic therapy in the elderly and senile age: the consensus opinion of experts of the Russian Association of Gerontologists and Geriatricians and the National Society of Preventive Cardiology. Cardiovascular Therapy and Prevention. 2021;20(3):2847. (In Russ.) DOI: 10.15829/1728-8800-2021-2847.
6. Vorobyova NM, Tkacheva ON. Use of oral anticoagulants in elderly patients with geriatric syndromes: what’s new? Rational Pharmacotherapy in Cardiology. 2020;16(6):984-93. (In Russ.) DOI: 10.20996/1819-6446-2020-12-03.
7. Sychev DA, Chernyaeva MS, Rozhkova MA, et al. Safety of direct oral anticoagulants in the treatment of atrial fibrillation in geriatric patients: focus on clinically relevant non-major bleeding. Pharmateca. 2024;2024;31(4):8-23. (In Russ.) DOI: 10.18565/pharmateca.2024.4.8-23.
8. Chernyaeva MS, Rozhkova MA, Kondrakhin AP, et al. Frequency and Structure of Clinically Relevant Non- Major Bleeding During Direct Oral Anticoagulants in Patients Over 80 Years Old with Non-Valvular Atrial Fibrillation. Effective Pharmacotherapy. 2024;20(6):28-38. DOI: 10.33978/2307-3586-2024-20-26-28-38.
9. Catalani F, Campello E, Occhipinti G, et al. Efficacy and safety of direct oral anticoagulants in older adults with atrial fibrillation: a prospective single- centre cohort study. Intern Emerg Med. 2023;18(7):1941-9. DOI: 10.1007/s11739-023-03375-9.
10. By the 2023 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-81. DOI: 10.1111/jgs.183724.
11. Sychev DA, Cherniaeva MS, Rozhkova MS, Vorobyova AE. Potentially Inappropriate Medications for Use in Older Adults: Beers Criteria (2023 American Geriat rics Society Guidelines). Safety and Risk of Pharmacotherapy. 2024;12(3):253-67. (In Russ.) DOI: 10.30895/2312-7821-2024-420.
12. Cherniaeva MS, Rozhkova MA, Kazakova MV, et al. Experience of using Beers criteria in clinical practice (according to Russian literature). FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2024;17(3):384-95. (In Russ.) DOI: 10.17749/2070-4909/farmakoekonomika.2024.262.
13. Sychev DA, Ostroumova OD, Pereverzev AP, et al. Risk factors for drug-induced diseases. Part 3. Drug-drug interactions and drug-food interactions. Pharmateca. 2022;29(1):10-8. (In Russ.) DOI: 10.18565/pharmateca.2022.1.10-18.
14. Sychev IN, Fedina LV, Gabrielyan DA, et al. Anticoagulant therapy with direct oral anticoagulants in conditions of polypharmacy: a course for safety. Medical Council. 2022;16(17):52-64. (In Russ.) DOI: 10.21518/2079-701X-2022-16-17-52-64.
15. Launbjerg J, Egeblad H, Heaf J, et al. Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients. J Intern Med. 1991;229(4):351-5. DOI: 10.1111/j.1365-2796.1991.tb00358.x.
Supplementary files
Review
For citations:
Cherniaeva M.S., Rozhkova M.A., Ilyina E.S., Moiseeva E.A., Gorelov E.A., Egorova L.A., Maslennikova O.M., Lomakin N.V., Sychev D.A. The Beers criteria role in predicting bleeding during the use of direct oral anticoagulants in patients with atrial fibrillation over 80 years of age. Rational Pharmacotherapy in Cardiology. 2025;21(1):39-46. (In Russ.) https://doi.org/10.20996/1819-6446-2025-3157